11514538

Summary
Title
Vascular endothelial growth factor 165 (VEGF(165)) activities are inhibited by carboxymethyl benzylamide dextran that competes for heparin binding to VEGF(165) and VEGF(165).KDR Complexes.
Authors
  • Hamma-Kourbali Y
  • Vassy R
  • Starzec A
  • Le Meuth-Metzinger V
  • Oudar O
  • Bagheri-Yarmand R
  • Perret G
  • Crépin M
Source
J Biol Chem
Publication Date
2001 Oct 26
PubMed ID
11514538

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024